BostonGene, a leader in AI-powered solutions for drug discovery and development, is transforming how pharmaceutical companies develop, target, and deliver cancer therapies — making precision ...

From cancer to infectious diseases to neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease, there ...

Drug discovery has traditionally been slow and expensive, often taking decades and costing manufacturers billions. But with quantum computing, that's all changing.

Regulatory science also plays a crucial role in ensuring public trust in these products and facilitating the translation of ...

Artificial intelligence. Researchers use AI in the drug discovery and development process to rapidly screen billions of molecules and identify potential compounds against validated biological targets.

With a $150 million boost in funding, the company aims to integrate advanced AI models with extensive datasets into the drug ...

The Global AI in Drug Discovery and Development Market is expected to reach at a CAGR of 18.5% during the forecast period 2025-2033. The AI in Drug Discovery and Development Market is expanding ...

Oxana Iliach is a Senior Director of Regulatory Strategy at Certara (PA, USA), a biotech company that offers comprehensive solutions for transforming and accelerating drug development. In her spare ...

Dotmatics, an early research and development company, says they're using AI to help accelerate the timeline in drug discoveries. "The art of drug discovery is really finding drugs in these massive ...

Both RXRX and SDGR have the potential to shift the paradigm of drug discovery and development, which has ... Recursion Pharmaceuticals’ shares currently trade at 1.78 times its book value, much ...

BMY can make up ground with AI, however, as the company says the technology is "at the forefront" of its drug discovery and development. "Integrating AI across various functions, we enhance ...